300255.SZ
300255.SZ
CNE1000016C2
CHANGSHAN PHARMA
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Market & Enterprise Value
Market Cap
20.36B EUR
21.52B EUR
34.35B EUR
Enterprise Value
22.94B EUR
24.13B EUR
36.84B EUR
Valuation Multiples
Trailing P/E
--
--
--
Forward P/E
--
--
--
Price to Sales
23.69x
23.85x
36.48x
Price to Book
17.14x
18.12x
28.39x
EV/Revenue
26.69x
26.73x
39.13x
EV/EBITDA
-151.59x
--
--
Price to FCF (P/FCF)
--
--
--
EV/FCF
--
--
--
FCF Yield
-0.87%
-0.62%
-0.06%
ende